Autres langues Takeda Pharmaceutical Company Limited Börse Stuttgart

Actions

TKDA

US8740602052

Produits pharmaceutiques

Marché Fermé - Börse Stuttgart 07:37:12 08/10/2026			Pré-ouverture 07:55:39
16,10 ^EUR	-1,23%		16,35	+1,55%

07/10	Un groupe pharmaceutique poursuit le gouvernement américain au sujet de la réglementation sur le prix des médicaments de Medicare	MT
07/10	Les actions asiatiques cotées aux États-Unis sous forme de certificats de dépôt américains chutent lors des échanges de mercredi	MT

Autres langues

07/10	Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule
07/10	Asian Equities Traded in the US as American Depositary Receipts Tumble in Wednesday Trading
30/09	Asian Equities Traded in the US as American Depositary Receipts Rise Modestly in Wednesday Trading
30/09	Takeda Reports New Psoriasis Treatment Outperformed Competitor in Phase 3 Trial
30/09	Takeda Pharmaceutical Company Limited Announces New Phase 3 Head-To-Head Results for Zasocitinib
30/09	Zasocitinib Delivered Superior Efficacy Versus Deucravacitinib in New Phase 3 Head-to-Head Results, Reinforcing Potential to Deliver Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill
29/09	Keros Therapeutics Expects $20 Million Milestone Payment From Takeda
29/09	Ginkgo Datapoints, Apheris, AbbVie, and Others Form Antibody Developability Consortium
29/09	Pharma sector doubles down on AI to slash costs, timelines
23/09	Two announcments for Roche
23/09	Aktien Schweiz Vorbörse: SMI freundlich erwartet - Nahosthoffnungen und Ölpreis
23/09	Roche proposes former Takeda CEO for board seat
23/09	Roche schlägt Christophe Weber zur Wahl in den Verwaltungsrat vor
22/09	Takeda Pharmaceutical Company Limited Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research Led by Phase 3 Arcotatug Tavatecan Data At Esmo 2026
22/09	Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026
21/09	Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on
21/09	Pharma sector doubles down on AI to slash costs, timelines
21/09	Takeda Announces Appointment of Enrique Vázquez as Head of Public Affairs in Spain
18/09	Dr. Reddy's, Takeda Sign Deal to Distribute QDENGA Dengue Vaccine in India
18/09	Dr. Reddy's Enters Agreement to Bring Takeda's Dengue Vaccine to India
18/09	Takeda Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems
18/09	Dr Reddy's signs India distribution deal for Takeda's Qdenga dengue vaccine
16/09	Pharma sector doubles down on AI to slash costs, timelines
14/09	Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Monday Trading
14/09	U.S. FDA Grants Priority Review to Takeda Pharmaceutical's Zasocitinib NDA for Plaque Psoriasis